Apax Partners buys Unilabs from Nordic Capital and Apax Partners France

Apax Partners invested via its Apax IX vehicle, acquiring its stake from Nordic Capital Fund VI and Apax France VII, a vehicle managed by Apax Partners France. Meanwhile, Apax Partners' Apax Europe VI will retain its stake in the business. Financial details surrounding the transaction have not been disclosed.

As part of the deal, Apax Partners France and Nordic Capital fully exited the business while the company's CEO, Jos Lamers, and the management team will retain their role in the business.

According to a statement, the capital injection will allow the company to boost its M&A strategy and further consolidate the European laboratory space.

Previous funding
In November 2007, Apax Partners France and Nordic Capital took the company private from the Swiss stock exchange and subsequently merged it with the diagnostics division of healthcare provider Capio in 2008. As part of the deal, Capio acquired a 98.13% stake in Unilabs, according to unquote" data.

Company
Founded in 1987, Unilabs is a clinical laboratory testing and medical diagnostics provider based in Geneva. The company manages 112 laboratories and 43 medical imaging units, with a presence in in Denmark, Finland, France, Italy, Norway, Portugal, Russia, Spain, Sweden and the UK.

The company has 5,300 employees and generated €673m in revenues in 2015, according to a statement.

People
Apax Partners – Steven Dyson (partner); Arthur Brothag (principal).
Nordic Capital – Fredrik Näslund (partner).
Apax Partners France – Bertrand Pivin (partner).
Unilabs – Jos Lamers (CEO).

Advisers
Equity – Simpson Thacher & Bartlett (legal); Vinge (legal).
Vendor (Nordic Capital) – Rotschild & Co (M&A); Mannheimer Swartling (legal).
Vendor (Apax Partners France) – Rotschild & Co (M&A); Allen & Overy (legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• Healthcare
• DACH
• Exits
• Switzerland
• Apax Partners
• Nordic Capital
• Secondary buyout